You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Epidermolysis Bullosa Dystrophica

Showing 26 - 50 of 134
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patients With Recessive Dystrophic Epidermolysis Bullosa

Recruiting
  • Epidermolysis Bullosa Dystrophica
    • Stanford, California
      Stanford University School of Medicine
    Mar 17, 2021

    Epidermolysis Bullosa Trial in Aurora, Chicago, New York (Palifermin, Fludarabine, Busulfan)

    Terminated
    • Epidermolysis Bullosa
    • Aurora, Colorado
    • +2 more
    Aug 13, 2021

    Epidermolysis Bullosa Dystrophica Trial in Toronto (SASS)

    Active, not recruiting
    • Epidermolysis Bullosa Dystrophica
    • SASS
    • Toronto, Ontario, Canada
      The Hospital for Sick Children
    Jan 25, 2021

    Dystrophic Epidermolysis Bullosa, DEB - Dystrophic Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa Trial in

    Recruiting
    • Dystrophic Epidermolysis Bullosa
    • +3 more
    • Open Label Topical Beremagene Geperpavec (B-VEC)
    • Rancho Santa Margarita, California
    • +5 more
    Jun 7, 2021

    Patients With Dystrophic Epidermolysis Bullosa (EBD)

    Unknown status
    • Dystrophic Epidermolysis Bullosa
    • Decriptive study of EDB
    • Nice, France
    • +1 more
    Feb 12, 2021

    Long-Term Follow-up Protocol

    Recruiting
    • Dystrophic Epidermolysis Bullosa
    • +2 more
      • Rancho Santa Margarita, California
      • +2 more
      Jun 7, 2021

      Recessive Dystrophic Epidermolysis Bullosa Trial in Redwood City, Aurora, Philadelphia (PTR-01, Normal saline)

      Completed
      • Recessive Dystrophic Epidermolysis Bullosa
      • Redwood City, California
      • +2 more
      Mar 8, 2021

      Epidermolysis Bullosa Dystrophica, Epidermolysis Bullosa Trial in Stanford (LZRSE-Col7A1 Engineered Autologous Epidermal Sheets)

      Active, not recruiting
      • Epidermolysis Bullosa Dystrophica
      • Epidermolysis Bullosa
      • LZRSE-Col7A1 Engineered Autologous Epidermal Sheets
      • Stanford, California
        Stanford University School of Medicine
      Oct 23, 2020

      Recessive Dystrophic Epidermolysis Bullosa Trial in Los Angeles (Gentamicin)

      Unknown status
      • Recessive Dystrophic Epidermolysis Bullosa
      • Los Angeles, California
        University of Southern California
      Nov 2, 2020

      Short Term Observational Study in DEB Patients

      Completed
      • Dystrophic Epidermolysis Bullosa
        • Chicago, Illinois
        • +9 more
        Mar 15, 2021

        Epidermolysis Bullosa, Oral Ulcer Trial in Santiago (Dentoxol mouthrinse dosages)

        Enrolling by invitation
        • Epidermolysis Bullosa
        • Oral Ulcer
        • Dentoxol mouthrinse dosages
        • Santiago, Región Metropolitana, Chile
          Facultad de Odontología, Universidad de Chile
        Apr 6, 2022

        Epidermolysis Bullosa Trial in Minneapolis (allo-APZ2-OTS, Placebo)

        Not yet recruiting
        • Epidermolysis Bullosa
        • Minneapolis, Minnesota
          Masonic Cancer Center and Medical Center Minneapolis
        Apr 20, 2023

        Recessive Dystrophic Epidermolysis Bullosa Trial in Seoul (Human Umbilical Cord Blood-derived Mesenchymal Stem Cells)

        Completed
        • Recessive Dystrophic Epidermolysis Bullosa
        • Human Umbilical Cord Blood-derived Mesenchymal Stem Cells
        • Seoul, Korea, Republic of
          GangnamSeverance Hospital
        Aug 17, 2020

        Generalized Epidermolysis Bullosa Simplex Trial (AC-203, Vehicle)

        Not yet recruiting
        • Generalized Epidermolysis Bullosa Simplex
        • (no location specified)
        Oct 3, 2023

        Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)

        Completed
        Has Results
        • Epidermolysis Bullosa
        • Serlopitant Tablet
        • Placebo Oral Tablet
        • Redwood City, California
          Stanford University
        Nov 30, 2022

        Molecular Signatures of Cutaneous Squamous Cell Carcinoma During

        Not yet recruiting
        • Recessive Dystrophic Epidermolysis Bullosa
          • (no location specified)
          Feb 24, 2020

          Hereditary Epidermolysis Bullosa Trial in Paris (Cannabidiol)

          Not yet recruiting
          • Hereditary Epidermolysis Bullosa
          • Paris, France
            Hôpital Necker Enfants Malades
          Dec 7, 2022

          Epidermolysis Bullosa Trial in Chicago (APR-TD011)

          Not yet recruiting
          • Epidermolysis Bullosa
          • APR-TD011
          • Chicago, Illinois
            Ann & Robert H. Lurie Children's Hospital of Chicago
          Sep 6, 2022

          Epidermolysis Bullosa Trial (allo-APZ2-OTS, Placebo)

          Not yet recruiting
          • Epidermolysis Bullosa
          • (no location specified)
          Jul 18, 2022

          Epidermolysis Bullosa Simplex Trial in Redwood City (TolaSure Topical Gel, Vehicle Topical Gel)

          Recruiting
          • Epidermolysis Bullosa Simplex
          • TolaSure Topical Gel
          • Vehicle Topical Gel
          • Redwood City, California
            Stanford University School of Medicine, Dermatology Department
          Jul 18, 2022

          Junctional Epidermolysis Bullosa Non-Herlitz Type Trial in Paris, Modena (Transplantation)

          Recruiting
          • Junctional Epidermolysis Bullosa Non-Herlitz Type
          • Paris, France
          • +1 more
          Aug 8, 2022

          Complex Care Training of Hereditary Epidermolysis Bullosa on

          Not yet recruiting
          • Hereditary Epidermolysis Bullosa
          • Complex Care Training of Hereditary Epidermolysis Bullosa
          • Paris, France
            Assistance Publique - Hôpitaux de Paris
          Feb 9, 2022

          Epidermolysis Bullosa (EB), Epidermolysis Bullosa Simplex, Dystrophic Epidermolysis Bullosa Trial in Palo Alto, Chicago, Chapel

          Completed
          Has Results
          • Epidermolysis Bullosa (EB)
          • +3 more
          • Diacerein 1% Ointment
          • Palo Alto, California
          • +2 more
          Feb 4, 2020

          Participants Previously Treated With EB-101 for Treatment of

          Enrolling by invitation
          • RDEB
          • EB-101
          • Redwood City, California
          • +1 more
          Feb 1, 2023

          Junctional Epidermolysis Bullosa Trial in Salzburg (Transplantation surgery of genetically corrected cultured epidermal

          Terminated
          • Junctional Epidermolysis Bullosa
          • Transplantation surgery of genetically corrected cultured epidermal autograft (ATMP)
          • Salzburg, Austria
            EB House Austria, Department of Dermatology, Paracelsus Medical
          Feb 18, 2022